Gene · 657
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients. | Cancers (Basel) | 2022 | 36139606 | PubTator, text mining | PubMed |
| Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts. | Cureus | 2022 | 36134040 | PubTator, text mining | PubMed |
| The Prominent Role of miR-942 in Carcinogenesis of Tumors. | Adv Biomed Res | 2022 | 36133499 | PubTator, text mining | PubMed |
| Editorial: TGF-β and BMP signaling in cancer. | Front Cell Dev Biol | 2022 | 36120575 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
| Association of the TGFβ gene family with microenvironmental features of gastric cancer and prediction of response to immunotherapy. | Front Oncol | 2022 | 36119489 | PubTator, text mining | PubMed |
| The identification of a novel frameshift insertion mutation in the EXT1 gene in a Chinese family with hereditary multiple exostoses. | Clin Case Rep | 2022 | 36101782 | PubTator, text mining | PubMed |
| Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine. | EBioMedicine | 2022 | 36099812 | PubTator, text mining | PubMed |
| Molecular characterization, clinical relevance and immune feature of m7G regulator genes across 33 cancer types. | Front Genet | 2022 | 36092891 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments. | Front Cardiovasc Med | 2022 | 36082126 | PubTator, text mining | PubMed |
| The Strong Protective Action of Ce3+/F- Combined Treatment on Tooth Enamel and Epithelial Cells. | Nanomaterials (Basel) | 2022 | 36080071 | PubTator, text mining | PubMed |
| Analyzing protein conjugation reactions for antibody-drug conjugate synthesis using polarized excitation emission matrix spectroscopy. | Biotechnol Bioeng | 2022 | 36071600 | PubTator, text mining | PubMed |
| Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. | Cancer Sci | 2022 | 36065483 | PubTator, text mining | PubMed |
| Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab. | J Oncol | 2022 | 36065307 | PubTator, text mining | PubMed |
| circ_0061265 competitively binds to microRNA-885-3p to promote the development of gastric cancer by upregulating AURKA expression. | Cancer Cell Int | 2022 | 36064409 | PubTator, text mining | PubMed |
| Adenomatous Polyposis Phenotype in BMPR1A and SMAD4 Variant Carriers. | Clin Transl Gastroenterol | 2022 | 36049049 | PubTator, text mining | PubMed |
| Decoding mechanism of action and sensitivity to drug candidates from integrated transcriptome and chromatin state. | Elife | 2022 | 36043458 | PubTator, text mining | PubMed |
| TGFß Gene Members and Their Regulatory Factors in Granulosa Compared to Cumulus Cells in PCOS: A Case-Control Study. | Cell J | 2022 | 36043409 | PubTator, text mining | PubMed |
| Endothelin-1 alters BMP signaling to promote proliferation of pulmonary artery smooth muscle cells. | Can J Physiol Pharmacol | 2022 | 36037530 | PubTator, text mining | PubMed |
| Real-World Evaluation of a Population Germline Genetic Screening Initiative for Family Medicine Patients. | J Pers Med | 2022 | 36013246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/657/papers?page=26